Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Feasibility of Lung Cancer Screening in High-risk Black Individuals

NCT05898594 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05898594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05898594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Feasibility of Lung Cancer Screening in High-risk Black Individuals
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 6, 2023
Completion date
June 30, 2028
Enrollment
900 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung carcinoma